Navigation Links
Marken Strengthens Clinical Trial Distribution Capabilities
Date:1/10/2012

LONDON, Jan. 10, 2012 /PRNewswire/ -- Marken is pleased to announce that Dr. Andrea Zobel has joined Marken in the new role of Senior Director, CTD Operations.  In this capacity she will assume responsibility for all activities within the growing network of Marken operated Clinical Trial Depots once they are completed and qualified for use and also manage the relationship with their affiliate depot network.

(Logo:  http://photos.prnewswire.com/prnh/20110930/NY78064LOGO )

Dr. Zobel is a biochemist by training and spent her early career in drug development as an assistant professor at the Institute for Pharmacology, Freie Universitat Berlin then as Head of Preclinical Development at ActinoDrug Pharmaceuticals, Henningsdorf.  Since 2004 Andrea has worked for Parexel International building unparalleled experience as Director Clinical Logistics Europe and Head of Global Center of Excellence Clinical Trial Supply both building and running a business with annual revenues in excess of USD 50 million.   She has a deep knowledge of managing strategic partnerships within the pharmaceutical industry, specialist knowledge in managing clinical trials logistics worldwide but particularly within Europe and a passion for professional Project Management. 

"We are excited to welcome Andrea to our team, her expertise and knowledge of the industry further strengthens the market leadership of Marken's Clinical Trial Distribution service line,"  Marken CEO, Wes Wheeler commented. "Our continued enhancement of our purpose build Pharmaceutical Service Depot network establishes Marken as the clear choice for innovative global clinical supply chain solutions."

Marken the premium provider of life science logistics solutions reinforces its commitment to the Clinical Trial Distribution (CTD) business by accelerating the creation of their global network of Clinical Trial Depots.  The company plans to expand its current network of depots to 12 fully owned and operated facilities in 2012 and is supported by an extensive network of third party service providers.

Andrea will be based in the new Marken Berlin office which is scheduled to begin operation in the first quarter of 2012.

About Marken
Marken is the leading global clinical supply chain service provider dedicated to the pharmaceutical and life sciences industries, supporting over 6,000 investigator sites in more than 100 countries. With decades of experience in the logistics, transport and distribution of temperature sensitive life saving pharmaceuticals, clinical trial supplies and specimen collection; Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies. Our team members and network of facilities bridge the distance between patients and the essential resources of life science companies.


'/>"/>
SOURCE Marken
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Unveils New Japan Office
2. Marken Rapidly Responds to Global Supply Chain Security Measures
3. Marken Announces the Opening of a Directly Owned Clinical Trial Supply Depot in Singapore
4. Marken Announces Appointment of Christopher OConnell as New Chief Financial Officer
5. Marken Announces Its New Logistics Operating System: Maestro™
6. Marken Appoints New Head of Global Quality Assurance
7. Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
8. PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru
9. Pepscan Therapeutics Strengthens Management Team
10. Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering
11. Lotus Pharmaceuticals, Inc. Strengthens Beijing Presence with Direct Sales to Drug Stores
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... Non-invasive diagnostic test realizes the ... ,Technology to be presented at Yissum’s booth, at IATI-BIOMED ... Company of the Hebrew University of Jerusalem announced ... Aurum Ventures MKI, the technology investment arm of Morris ... approach for early detection of multiple diseases by analyzing ...
(Date:5/23/2016)... JERUSALEM , May 23, 2016 ... therapies for the treatment of cancer and orphan genetic ... of up to $4.4 million from the Israel Innovation ... the Israeli Ministry of Economy and Industry. The mission ... and entrepreneurship in various industries, including science and technology, ...
(Date:5/23/2016)... , May 23, 2016   Purdue ... entered into an agreement with Egalet Corporation and ... claims. As part of the agreement the companies ... will enable all three companies to develop and ... "This agreement reflects the commitment of ...
Breaking Medicine Technology:
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... ... announce the participation of high-level representatives from the Japan PMDA, US FDA, industry ... will address how CDISC standards help format data from clinical trials so that ...
(Date:5/23/2016)... , ... May 23, 2016 , ... ... Texas Veterinary Medical Association (TVMA) reminds pet owners that intervening at the first ... Heatstroke occurs when a pet’s normal body mechanisms cannot keep the body’s temperature ...
(Date:5/23/2016)... Hollywood, California (PRWEB) , ... May 23, 2016 ... ... Luciana Lagana specializes in research on discriminated minorities’ quality of life and ... this purpose, she is creating advocacy documentaries to be tested through research to ...
(Date:5/23/2016)... , ... May 23, 2016 , ... ... on its Chesterfield, Missouri, campus, Standard Process Inc. awarded $6,000 in ... Siewert and Chloe Tillman. Each student is in her fifth trimester of classes ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... to residents of Westchester County for over 24 years, recently hosted its sixth ... members joined HOW for two remembrance ceremonies, each concluding with the release of ...
Breaking Medicine News(10 mins):